Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) and Novogen Limited (NASDAQ:NVGN) Added to Growing Stock Report's NASDAQ Gainers Watch List.

New York, NY -- (SBWIRE) -- 02/20/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) and Novogen Limited (NASDAQ:NVGN)

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) a development-stage pharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceutical products is currently up (+94.64%) on 9,558,542 shares traded after the company said Wednesday it expects to resubmit a blood-pressure drug application. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) is currently up (+125.71%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Chelsea Therapeutics International Ltd. (NASDAQ:CHTP)

Novogen Limited (NASDAQ:NVGN) a biotechnology company that engages in the research and development of prescription drugs is up (+40.96%) on 1,694,453 shares traded following Novogen recent strength attributed to positive study results on its ovarian cancer drug CS-6. Novogen Limited (NASDAQ:NVGN) is currently up (+1920.83%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Novogen Limited (NASDAQ:NVGN)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com